HCPCS Code Q2043 | Description & Billing Guidelines

HCPCS Code Q2043 | Description & Billing Guidelines

HCPCS Q2043 can be billed for one unit of sipuleucel–T for treating metastatic hormone-refractory prostate cancer. 1. What Is HCPCS Code Q2043? HCPCS Q2043 covers the supply of sipuleucel–T for treating metastatic, hormone-refractory prostate cancer. One unit of Q2043 represents a dose of a minimum of 50 million autologous cd54+ cells activated with prostatic acid phosphatase…